13F HOLDINGS REPORT
Frazier Life Sciences Management, L.P.
Quarter ended Q2 2024 · Filed August 15, 2024 · Accession 0001892134-24-000004
Total Value
$2.14B
Positions
49
Other Managers
0
Confidential Omitted
No
Holdings (49)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 12,226,943 | $234.9M | 10.99% |
| 2 | MIRUM PHARMACEUTICALS INC | MIRM | 6,495,392 | $222.1M | 10.39% |
| 3 | KRYSTAL BIOTECH INC | KRYS | 988,460 | $181.5M | 8.49% |
| 4 | HILLEVAX INC | 43157M102 | 10,617,062 | $153.5M | 7.18% |
| 5 | PHATHOM PHARMACEUTICALS INC | PHAT | 10,109,279 | $104.1M | 4.87% |
| 6 | RHYTHM PHARMACEUTICALS INC | RYTM | 2,371,304 | $97.4M | 4.55% |
| 7 | BRIDGEBIO PHARMA INC | BBIO | 3,632,604 | $92.0M | 4.30% |
| 8 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 8,785,284 | $81.7M | 3.82% |
| 9 | DISC MEDICINE INC | IRON | 1,754,834 | $79.1M | 3.70% |
| 10 | VAXCYTE INC | PCVX | 1,039,405 | $78.5M | 3.67% |
| 11 | EDGEWISE THERAPEUTICS INC | EWTX | 3,731,067 | $67.2M | 3.14% |
| 12 | ANAPTYSBIO INC | ANABV | 2,165,591 | $54.3M | 2.54% |
| 13 | VERONA PHARMA PLC | 925050106 | 3,314,349 | $47.9M | 2.24% |
| 14 | KALVISTA PHARMACEUTICALS INC | KALV | 3,687,867 | $43.4M | 2.03% |
| 15 | TARSUS PHARMACEUTICALS INC | TARS | 1,587,527 | $43.1M | 2.02% |
| 16 | REVOLUTION MEDICINES INC | RVMDW | 997,455 | $38.7M | 1.81% |
| 17 | ERASCA INC | ERAS | 16,216,216 | $38.3M | 1.79% |
| 18 | AGIOS PHARMACEUTICALS INC | AGIO | 871,974 | $37.6M | 1.76% |
| 19 | SOLENO THERAPEUTICS INC | SLNO | 875,667 | $35.7M | 1.67% |
| 20 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,561,230 | $33.6M | 1.57% |
| 21 | SAVARA INC | SVRA | 8,157,385 | $32.9M | 1.54% |
| 22 | ORIC PHARMACEUTICALS INC | ORIC | 4,142,855 | $29.3M | 1.37% |
| 23 | CG ONCOLOGY INC | CGON | 770,000 | $24.3M | 1.14% |
| 24 | PEPGEN INC | PEPG | 1,502,788 | $24.0M | 1.12% |
| 25 | MERUS N V | N5749R100 | 373,100 | $22.1M | 1.03% |
| 26 | TREVI THERAPEUTICS INC | TRVI | 7,381,090 | $22.0M | 1.03% |
| 27 | SILENCE THERAPEUTICS PLC | SLNCF | 1,148,591 | $21.8M | 1.02% |
| 28 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 425,000 | $17.5M | 0.82% |
| 29 | AUTOLUS THERAPEUTICS PLC | AUTL | 4,623,324 | $16.1M | 0.75% |
| 30 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 393,000 | $16.1M | 0.75% |
| 31 | MEREO BIOPHARMA GROUP PLC | MREO | 4,401,371 | $15.8M | 0.74% |
| 32 | IMMATICS N.V | IMTX | 1,152,456 | $13.4M | 0.63% |
| 33 | TYRA BIOSCIENCES INC | TYRA | 832,220 | $13.3M | 0.62% |
| 34 | MACROGENICS INC | MGNX | 3,010,727 | $12.8M | 0.60% |
| 35 | APPLIED THERAPEUTICS INC | 03828A101 | 2,286,135 | $10.7M | 0.50% |
| 36 | PUMA BIOTECHNOLOGY INC | PBYI | 3,062,558 | $10.0M | 0.47% |
| 37 | 89BIO INC | 282559103 | 1,000,000 | $8.0M | 0.37% |
| 38 | ELEVATION ONCOLOGY INC | 28623U101 | 2,958,579 | $8.0M | 0.37% |
| 39 | COGENT BIOSCIENCES INC | COGT | 936,576 | $7.9M | 0.37% |
| 40 | ACADIA PHARMACEUTICALS INC | ACAD | 470,338 | $7.6M | 0.36% |
| 41 | ARVINAS INC | ARVN | 285,331 | $7.6M | 0.36% |
| 42 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 1,069,244 | $7.3M | 0.34% |
| 43 | ALLOGENE THERAPEUTICS INC | ALLO | 2,867,750 | $6.7M | 0.31% |
| 44 | AN2 THERAPEUTICS INC | ANTX | 2,088,889 | $4.5M | 0.21% |
| 45 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 500,333 | $4.4M | 0.20% |
| 46 | DESIGN THERAPEUTICS INC | DSGN | 1,195,179 | $4.0M | 0.19% |
| 47 | IMMUNOCORE HLDGS PLC | IMCR | 108,762 | $3.7M | 0.17% |
| 48 | METAGENOMI INC | MGX | 245,692 | $1.0M | 0.05% |
| 49 | ACLARIS THERAPEUTICS INC | ACRS | 264,377 | $290,815 | 0.01% |